The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
Open accessAbstract
The cannabinoid receptor type 1 (CB1) and its endogenous ligands, the endocannabinoids, are involved in the regulation of food intake. Here we show that the lack of CB1 in mice with a disrupted CB1 gene causes hypophagia and leanness. As compared with WT (CB1+/+) littermates, mice lacking CB1 (CB1-/-) exhibited reduced spontaneous caloric intake and, as a consequence of reduced total fat mass, decreased body weight. In young CB1-/- mice, the lean phenotype is predominantly caused by decreased caloric intake, whereas in adult CB1-/- mice, metabolic factors appear to contribute to the lean phenotype. No significant differences between genotypes were detected regarding locomotor activity, body temperature, or energy expenditure. Hypothalamic CB1 mRNA was found to be coexpressed with neuropeptides known to modulate food intake, such as corticotropin-releasing hormone (CRH), cocaine-amphetamine-regulated transcript (CART), melanin-concentrating hormone (MCH), and preproorexin, indicating a possible role for endocannabinoid receptors within central networks governing appetite. CB1-/- mice showed significantly increased CRH mRNA levels in the paraventricular nucleus and reduced CART mRNA levels in the dorsomedial and lateral hypothalamic areas. CB1 was also detected in epidydimal mouse adipocytes, and CB1-specific activation enhanced lipogenesis in primary adipocyte cultures. Our results indicate that the cannabinoid system is an essential endogenous regulator of energy homeostasis via central orexigenic as well as peripheral lipogenic mechanisms and might therefore represent a promising target to treat diseases characterized by impaired energy balance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878 · cited 1×
“CART mRNA was abundantly expressed in the hypothalamus, especially in the supraoptic nucleus, PVN, VMN, dorsomedial nucleus (DMN), LHA, and ARC (30), whereas the expression of prepro-orexin and MCH mRNAs was restricted to the neurons localized in LHA and in the zona incerta (31, 32).”
BackgroundLedent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 2×
“Male mice deficient for CB1 (CB1–/–) and male WT littermates (CB1+/+), originally generated and genotyped as described earlier (19), were used.”
MethodSelf-citationLeptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559 · cited 3×
“Importantly, the levels of hypothalamic endocannabinoids were shown to be decreased after leptin administration, and the blockade of CB1 was demonstrated to inhibit starvation-induced hyperphagia in mice (17).”
BackgroundInfluentialBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“These observations, together with the presence of monoacylglycerol lipase in fat tissue, one of the main endocannabinoid-degrading enzymes (38, 39), strongly support adipose tissue as a novel physiologic and pharmacologic target for cannabinoid action.”
BackgroundHypothalamic CART is a new anorectic peptide regulated by leptin
Kristensen, P., Judge, M. E., Thim, L., Ribel, U., Christjansen, K. N., Wulff, B. S., Clausen, J. T., Jensen, P. B., Madsen, O. D., Vrang, N., et al. (1998) · Nature · doi:10.1038/29993 · Cited by 1,282
Neuropeptide Y Distribution in the Rat Brain
Allen, Y. S., Adrian, T. E., Allen, J. M., Tatemoto, K., Crow, T. J., Bloom, S. R., & Polak, J. M. (1983) · Science · doi:10.1126/science.6136091 · Cited by 1,096
Bittencourt, J. C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J. ‐., Vale, W., & Sawchenko, P. E. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903190204 · Cited by 1,075
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationChen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X.-M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., et al. (2000) · Nature Genetics · doi:10.1038/79254 · Cited by 894
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
Ravinet Trillou, C., Arnone, M., Delgorge, C., Gonalons, N., Keane, P., Maffrand, J.-P., & Soubrié, P. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00545.2002 · Cited by 566
Yanovski, S. Z., & Yanovski, J. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012586 · Cited by 544
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
Williams, C. M., & Kirkham, T. C. (1999) · Psychopharmacology · doi:10.1007/s002130050953 · Cited by 505
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R., & Gessa, G. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00322-1 · Cited by 487
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding
Gómez, R., Navarro, M., Ferrer, B., Trigo, J. M., Bilbao, A., Del Arco, I., Cippitelli, A., Nava, F., Piomelli, D., & Rodrı́guez de Fonseca, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09612.2002 · Cited by 486
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
Jamshidi, N., & Taylor, D. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704379 · Cited by 463
Qian, S., Chen, H., Weingarth, D., Trumbauer, M. E., Novi, D. E., Guan, X., Yu, H., Shen, Z., Feng, Y., Frazier, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5027-5035.2002 · Cited by 430
cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase
Karlsson, M., Contreras, J. A., Hellman, U., Tornqvist, H., & Holm, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27218 · Cited by 422
Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin
Inui, A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01292-2 · Cited by 318
Endogenous cannabinoid system as a modulator of food intake
Cota, D., Marsicano, G., Lutz, B., Vicennati, V, Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 315
Self-citationHermann, H., Marsicano, G., & Lutz, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00509-7 · Cited by 290
Self-citationThe distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain
Olschowka, J. A., O'Donohue, T. L., Mueller, G. P., & Jacobowitz, D. M. (1982) · Peptides · doi:10.1016/0196-9781(82)90071-7 · Cited by 276
SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
Simiand, J., Keane, M., Keane, P. E., & Soubrié, P. (1998) · PubMed · Cited by 264
Further studies on the anatomical distribution of CART by in situ hybridization
Couceyro, P. R., Koylu, E. O., & Kuhar, M. J. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00212-3 · Cited by 260
Hyperphagia in pre-fed rats following oral δ9-THC
Williams, C. M., Rogers, P. J., & Kirkham, T. C. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00170-x · Cited by 256
Hao, S., Avraham, Y., Mechoulam, R., & Berry, E. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00059-5 · Cited by 229
Delta-9-Tetrahydrocannabinol: Localization in Body Fat
Kreuz, D. S., & Axelrod, J. (1973) · Science · doi:10.1126/science.179.4071.391 · Cited by 191
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
Berry, E. M., & Mechoulam, R. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00257-7 · Cited by 184
Asnicar, M. A. (2001) · Endocrinology · doi:10.1210/en.142.10.4394 · Cited by 177
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 166
Self-citationAbbott, C. R. (2001) · Endocrinology · doi:10.1210/en.142.8.3457 · Cited by 158
Cannabis: Effects on hunger and thirst
Abel, E. L. (1975) · Behavioral Biology · doi:10.1016/s0091-6773(75)91684-3 · Cited by 157
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
Freedland, C. S., Poston, J. S., & Porrino, L. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00359-2 · Cited by 141
Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets
Koch, J. E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00467-1 · Cited by 129
Li, C., Chen, P., & Smith, M. S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02324-0 · Cited by 96
Physiology of transgenic mice with brown fat ablation: obesity is due to lowered body temperature
Klaus, S., Münzberg, H., Trüloff, C., & Heldmaier, G. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r287 · Cited by 90
Pagotto, U., Arzberger, T., Hopfner, Ú., Sauer, J., Renner, U., NEWTON, C. J., Lange, M., Uhl, E., Weindl, A., & Stalla, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118249 · Cited by 73
Self-citationNucleotide sequence and expression of the mouse corticotropin-releasing hormone gene
Seasholtz, A. F., Bourbonais, F., Harnden, C. E., & Camper, S. A. (1991) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(91)90054-r · Cited by 52
Mechoulam, R., & Fride, E. (2001) · Nature · doi:10.1038/35071214 · Cited by 51
Ailhaud, G. (2001) · Humana Press eBooks · doi:10.1385/1592592317 · Cited by 35
Hypothalamic peptides as drug targets for obesity
Dhillo, W. S., & Bloom, S. R. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00110-2 · Cited by 30
Linthorst, A. C. E., Karanth, S., Barden, N., Holsboer, F., & Reul, J. M. H. M. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00425.x · Cited by 21
Self-citationEffects of nutrition on the cell survival and gene expression of transplanted fat tissues in mice
Matsumoto, F., Bujo, H., Kuramochi, D., Saito, K., Shibasaki, M., Takahashi, K., Yoshimoto, S., Ichinose, M., & Saito, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00711-8 · Cited by 13
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…affect lipid metabolism through regulating the level of adiponectin production (Bensaid et al., 2003), by increasing lipoprotein lipase activity (Cota et al., 2003), or by inhibiting AMPactivated protein kinase (AMPK) (Kola et al., 2005), which leads to increased lipogenesis and decrease in…”
BackgroundInfluentialThe orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
“Recently, the liver and adipose has been added to the list (Cota et al., 2003; Osei-Hyiaman et al., 2005).”
BackgroundEndocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392
Metadata
- Authors
- Cota, D., Marsicano, G., Tschöp, M., Grübler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thöne-Reineke, C., Ortmann, S., Tomassoni, F., Cervino, C., Nisoli, E., Linthorst, A. C. E., Pasquali, R., Lutz, B., Stalla, G. K., & Pagotto, U.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-08-01
- Volume
- 112
- Issue
- 3
- Pages
- 423-431
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2073734463
- Cited by
- 1,168
- References
- 49
- FWCI
- 40.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.